Clinical Trials · NCT00730171

An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation

Name: An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Linaclotide

Phase: Phase 3
Recruitment status: Completed
Sponsor: Ironwood Pharmaceuticals, Inc.
Enrollment: 1,743
Start date: Sep 2008
Locations: 116 sites, United States
Primary endpoint: Number of Participants With at Least One Treatment-Emergent Adverse Event (TEAE)

View Linaclotide compound reference